The effect of turmeric on lipid profile, malondialdehyde, liver echogenicity and enzymes among patients with nonalcoholic fatty liver disease: a randomized double blind clinical trial

Table 4 Effects of turmeric on NAFLD degree in patients with NAFLD

NAFLD degree	Placebo n = 32	Turmeric n = 32	P1
Before intervention^α			0.787
Normal	0	0
Mild	23(71.9%)	24(75%)
Moderate	8(25%)	7(21.9%)
Severe	1(3.1%)	1(3.1%)
After intervention			0.271
Normal	1(3.1%)	2(6.2%)
Mild	24(75%)	26(81.2%)
Moderate	7(21.9%)	4(12.5%)
Severe	0	0
P2	0.102	0.020

NAFLD nonalcoholic fatty liver disease
^αData are expressed as n (%). P1 resulted from Mann–Whitney U test between the 2 groups and P2 resulted from Wilcoxon test within each group

ISSN: 1758-5996